Highlights:       

• Successful pilot-scale production of Flavocide® conducted by Rallis
• Demonstration that Flavocide® can be produced at a consistent quality and yield at pre- commercial scale
• Flavocide® produced by Rallis to be used in planned testing activities to advance the registration process for Flavocide
• Rallis has capacity to produce Flavocide® in sufficient quantities for future supply to Bio-Gene’s commercial licensees

Announcing the above, Dr Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said,

““With a long-standing history of agrochemicals manufacturing and strategic partnerships with global customers; Rallis is committed to supporting the development and commercialization of next-gen sustainable solutions for the Crop Protection and allied sectors. Our partnership with Bio-Gene for the successful process development and scale-up of their patented nature-identical Flavocide® insecticide is testament to that commitment. While Rallis does not expect the business to be material at this stage, we look forward to continuing to work closely with Bio-Gene to enable the successful global commercialization of Flavocide-based solutions over the next few years.” 

A copy of the joint statement released is enclosed herewith.

Flavocide® is a nature-identical product based on Flavesone, a naturally occurring plant compound present in some eucalypts. Bio-Gene has developed a proprietary process to synthesise the molecule and produce it in commercial quantities. Bio-Gene owns all intellectual property created by its contractors relating to the synthesis of Flavocide®.

The post Bio-Gene and Rallis India Limited achieve key Flavocide® production milestone appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.